P014: Prognostic significance of nutritional indexes (CONUT and PNI) in classical Hodgkin lymphoma patients

P014: Prognostic significance of nutritional indexes (CONUT and PNI) in classical Hodgkin lymphoma patients

Bibliographic Details
Main Authors:	Rita Costa E. Sousa, Cátia Almeida, Adriana Roque, Maria Carolina Afonso, Dulcelena Neves, Raquel Guilherme, Lenka Ruzickova, José Pedro Carda, Catarina Geraldes, Marília Gomes
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000890624.18867.98

Similar Items

P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose
by: Cátia Almeida, et al.
Published: (2022-10-01)

Research Progress of PNI and CONUT in Breast Cancer
by: XU XiaoFei, et al.
Published: (2022-09-01)

P014 (0098) CD47 IS EXPRESSED ON HODGKIN REED STERNBERG CELLS IN CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01)

Prognostic value of three clinical nutrition scoring system (NRI, PNI, and CONUT) in elderly patients with prostate cancer
by: Shu-ying Li, et al.
Published: (2024-10-01)

Controlling Nutritional Status (CONUT) Score and Prognostic Nutritional Index (PNI) Are Good Candidates for Prognostic Markers for Acute Pancreatitis
by: Mustafa Zanyar Akkuzu, et al.
Published: (2022-12-01)

Effect of Controlling Nutritional Status Score (CONUT) and Prognostic Nutritional Index (PNI) on patients after spinal tuberculosis surgery
by: Long-Yao Cao, et al.
Published: (2022-09-01)

Treatment Of Classical Hodgkin Lymphoma: The State Of The Art
by: Carmino Antonio de Souza, et al.
Published: (2023-10-01)

Do nutritional assessment tools (PNI, CONUT, GNRI) predict adverse events after spinal surgeries? A systematic review and meta-analysis
by: Zhi Huang, et al.
Published: (2024-05-01)

Hodgkin's variant of Richter transformation during ibrutinib therapy: A case report and review of the literature
by: Carolina Afonso, et al.
Published: (2022-10-01)

Genetics of classical Hodgkin Lymphoma
by: Gianluca Schiavoni, et al.
Published: (2018-06-01)

T014 (0118) MULTICENTRIC ITALIAN EXPERIENCE IN TREATMENT OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL) IN THE RITUXIMAB ERA
Published: (2018-10-01)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
by: Ahmet Dogan
Published: (2022-10-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
by: Dennis A. Eichenauer, et al.
Published: (2018-10-01)

Classical Hodgkin’s Lymphoma Presenting as Erythroderma
by: Kumar Parimalam, et al.
Published: (2022-11-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
by: Mikalai Katsin, et al.
Published: (2023-12-01)

Current directions in the treatment of classical Hodgkin lymphoma
by: Frank G. Keller, et al.
Published: (2023-11-01)

Bone marrow involvement by classic Hodgkin lymphoma
by: Mohammad Barouqa, et al.
Published: (2022-05-01)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
by: Soyoung Im, et al.
Published: (2022-11-01)

Combining prognostic nutritional index (PNI) and controlling nutritional status (CONUT) score as a valuable prognostic factor for overall survival in patients with stage I–III colorectal cancer
by: Harin Kim, et al.
Published: (2023-01-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
by: Hongyu Wang, et al.
Published: (2023-03-01)

Classical Hodgkin lymphoma following follicular lymphoma: a case report
by: Bomi Kim
Published: (2023-11-01)

The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future
by: S. E. Richardson, et al.
Published: (2011-01-01)

Hemophagocytic Lymphohistiocytosis in a Patient with Classical Hodgkin Lymphoma
by: G. Hyun, et al.
Published: (2016-01-01)

Classic Hodgkin lymphoma-nodular sclerosis – case report
by: Mihaela Lebedenco, et al.
Published: (2023-06-01)

Optimization of the first line treatment in classical Hodgkin's lymphoma
by: Pauline Brice
Published: (2018-06-01)

Cell-Free DNA for the Management of Classical Hodgkin Lymphoma
by: Vincent Camus, et al.
Published: (2021-03-01)

Composite lymphoma associating diffuse large B‐cell lymphoma with classical Hodgkin lymphoma
by: Maïlis Lauwers, et al.
Published: (2022-11-01)

P018 (0139) GATA3 EXPRESSION DISTINGUISHES CLASSIC HODGKIN LYMPHOMA FROM NODULAR LYMPHOCYTE HODGKIN LYMPHOMA
Published: (2018-10-01)

Validation of the pathological narcissistic inventory (PNI) and its brief form (B-PNI) in the Arabic language
by: Diana Malaeb, et al.
Published: (2023-03-01)

Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes
by: Jonas Juul Hansen, et al.
Published: (2018-01-01)

Severe Aplastic Anemia as First Manifestation of Classical Hodgkin Lymphoma
by: Cláudia L. Pedrosa, et al.
Published: (2021-01-01)

Cerebellar involvement in classical Hodgkin’s lymphoma: A case report
by: Suyash Chinchanikar, et al.
Published: (2024-09-01)

T026: Characterization of cancer-associated fibroblasts in classical Hodgkin lymphoma
by: Kristiina Karihtala, et al.
Published: (2022-10-01)

Scientific techniques in adolescent and young adult classic Hodgkin lymphoma
by: Francesco Maura, et al.
Published: (2023-11-01)

Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma
by: Julian Benckendorff, et al.
Published: (2021-06-01)

Macrophage Infiltration Correlates with Genomic Instability in Classic Hodgkin Lymphoma
by: Suzana Hančić, et al.
Published: (2022-03-01)

Synchronous Nodal Involvement of Metastatic Adenocarcinoma and Classical Hodgkin's Lymphoma
by: Ritesh Sachdev, et al.
Published: (2017-08-01)

Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01)